Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation by Pedro Silva Cunha, André Viveiros Monteiro, Madalena Coutinho Cruz, Paula Malveiro, João Pedro Reis, Guilherme Portugal, Ana Dias, Rui Cruz Ferreira, Mário Martins Oliveira

Subjects: “…non-vitamin K oral anticoagulants…”
Get full text

Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease by Mihai Ciprian Stoica, Zsolt Gáll, Mirela Liana Gliga, Carmen Denise Căldăraru, Orsolya Székely

Subjects: Get full text

How to effectively reverse life-thretening effects of non-vitamin K oral anticoagulants? by Łukasz Wołowiec, Joanna Banach, Daniel Rogowicz, Magdalena Węglarz, Walery Zukow, Władysław Sinkiewicz

Subjects: Get full text

How to effectively reverse life-thretening effects of non-vitamin K oral anticoagulants? by Łukasz Wołowiec, Joanna Banach, Daniel Rogowicz, Magdalena Węglarz, Walery Zukow, Władysław Sinkiewicz

Subjects: “…anticoagulation, non-vitamin k oral anticoagulants, new oral anticoagulants, idarucizumab…”
Get full text

Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation by Jovanović Dejana R.

Subjects: Get full text

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants by Alfredo Caturano, Raffaele Galiero, Pia Clara Pafundi

Subjects: Get full text

Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different? by Łukasz Wołowiec, Daniel Rogowicz, Krystian Kałużny, Anna Kałużna, Walery Zukow

Subjects: “…non-vitamin k oral anticoagulants, new oral anticoagulants, betrixaban, venous thromboembolism…”
Get full text

Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different? by Łukasz Wołowiec, Daniel Rogowicz, Krystian Kałużny, Anna Kałużna, Walery Zukow

Subjects: “…non-vitamin K oral anticoagulants…”
Get full text

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects by Lisa A. de Jong, Judith J. Gout-Zwart, Jelena Stevanovic, Harrie Rila, Mike Koops, Menno V. Huisman, Maarten J. Postma

Subjects: Get full text

Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non–Vitamin K Oral Anticoagulants Across Varying Body Mass Index by Astrid Fritz Hansson, Karin Jensevik Eriksson, Christina Christersson, Claes Held, Gorav Batra

Subjects: Get full text

Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation by M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin

Subjects: Get full text

Time trends in stroke risk management among high-risk patients with non-valvular atrial fibrillation in Australia between 2011–2019 by K. Giskes, N. Lowres, J. Orchard, K. Hyun, C. Hespe, B. Freedman

Subjects: Get full text

Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis by Fuwei Liu, Yupei Zhang, Jun Luo, Yue Zhou

Subjects: Get full text

Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR®) PINNACLE Registry by Lauren E. Thompson, Thomas M. Maddox, Lanyu Lei, Gary K. Grunwald, Steven M. Bradley, Pamela N. Peterson, Frederick A. Masoudi, Alexander Turchin, Yang Song, Gheorghe Doros, Melinda B. Davis, Stacie L. Daugherty

Subjects: Get full text

Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report by Waldemar Kafke, Peter Kraft, Department of Neurology

Subjects: Get full text

Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K o... by Rocco A. Montone, Giampaolo Niccoli, Vincenzo Tufaro, Silvia Minelli, Michele Russo, Federico Vergni, Luigi Sommariva, Francesco Pelliccia, Francesco Bedogni, Filippo Crea

Subjects: Get full text

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention by Marek Koziński, Joanna Rejszel-Baranowska, Elżbieta Młodawska, Jolanta M. Siller-Matula, Anna Tomaszuk-Kazberuk

Subjects: Get full text

Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) by Özer Badak, Ali Rıza Demir, Tugay Önal, Taylan Akgün, Osman Can Yontar, Ömer Şatıroğlu, Hakan Duman, Ertuğrul Okuyan, Mehmet Melek, İbrahim Etem Dural

Subjects: Get full text

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation by Jarosław Zalewski, Anetta Undas

Subjects: Get full text

Atrial fibrillation in elderly patients. Features of using rivaroxaban by A. D. Erlikh

Subjects: Get full text